Alphabet's plans to spend $10 billion more on capital expenditures this year than previously forecast seem "un-Googly," according to Bernstein analyst Mark Shmulik. And that might be holding the stock ...

The rise of artificial-intelligence agents, which can make decisions and take action, could give a boost to the biggest cloud-computing providers this earnings season, including Alphabet. Ted ...

See more on Alphabet's Q2'25 earnings preview with forecasts of $93.75B revenue, key growth drivers like AI & Cloud, and why ...

Google’s AI tools will help Alphabet stay competitive, Citizens JMP says. BNP Paribas Exane says all hyperscalers are challenged.

Nvidia Corporation's growth slows down amidst rising competition and risks from Alphabet's TPUs. Click for my updated look at the NVDA stock prospects.

Alphabet Inc. (NASDAQ:GOOGL) is among the Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy. On June 26, the company’s Google Cloud service and Pearson entered a multi-year partnership ...

Alphabet Inc. (NASDAQ:GOOGL) ranks among the best FAANG stocks to buy according to hedge funds. On June 26, Citizens JMP raised Alphabet Inc.

Most AI stocks are expensive, but not Alphabet or Applied Materials. Alphabet will benefit from both customer and cloud AI spending. Applied Materials is vital in the semiconductor supply chain ...

As the AI talent wars escalate, Google’s new arrangement with startup Windsurf shows tech companies see a lot of value in ...

Alphabet Inc. (NASDAQ:GOOGL) is one of the 12 Best Stocks to Buy and Hold for the Long Term. On June 10, Reuters reported that OpenAI has indicated its plans to add Alphabet Inc.

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is ...